{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:39:14Z","timestamp":1787755154705,"version":"build-2784847793"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    <jats:list list-type=\"plain\">\n                      <jats:list-item>\n                        <jats:p>\u27a2 In soft-tissue sarcomas (STSs), the use of positron emission tomography-computed tomography (PET-CT) through a standardized uptake value reduction rate correlates well with histopathological response to neoadjuvant treatment and survival.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\u27a2 PET-CT has shown a better sensitivity to diagnose systemic involvement compared with magnetic resonance imaging and CT; therefore, it has an important role in detecting recurrent systemic disease. However, delaying the use of PET-CT scan, to differentiate tumor recurrence from benign fluorodeoxyglucose uptake changes after surgical treatment and radiotherapy, is essential.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\u27a2 PET-CT limitations such as difficult differentiation between benign inflammatory and malignant processes, inefficient discrimination between benign soft-tissue tumors and STSs, and low sensitivity when evaluating small pulmonary metastases must be of special consideration.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:p>","DOI":"10.2106\/jbjs.rvw.22.00131","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T02:00:26Z","timestamp":1673661626000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["PET-CT in the Evaluation of Neoadjuvant\/Adjuvant Treatment Response of Soft-tissue Sarcomas"],"prefix":"10.2106","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4085-8442","authenticated-orcid":false,"given":"Samy","family":"Castillo-Flores","sequence":"first","affiliation":[{"name":"Medical Student at Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3352-6362","authenticated-orcid":false,"given":"Marcos R.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Medical Student at Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2396-4860","authenticated-orcid":false,"given":"Mayte","family":"Bryce-Alberti","sequence":"additional","affiliation":[{"name":"Medical Student at Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6784-5791","authenticated-orcid":false,"given":"Felipe","family":"de Souza","sequence":"additional","affiliation":[{"name":"Division of Musculoskeletal Radiology, Department of Radiology, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0943-1168","authenticated-orcid":false,"given":"Ty K.","family":"Subhawong","sequence":"additional","affiliation":[{"name":"Division of Musculoskeletal Radiology, Department of Radiology, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0074-6596","authenticated-orcid":false,"given":"Russ","family":"Kuker","sequence":"additional","affiliation":[{"name":"Division of Musculoskeletal Radiology, Department of Radiology, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4893-0341","authenticated-orcid":false,"given":"Juan","family":"Pretell-Mazzini","sequence":"additional","affiliation":[{"name":"Division of Orthopedic Oncology, Miami Cancer Institute, Baptist Health System South Florida, Plantation, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12]]},"reference":[{"issue":"4","key":"r1-20240731","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.soc.2016.05.001","article-title":"Refinements in sarcoma classification in the current 2013 World Health Organization classification of tumours of soft tissue and bone","volume":"25","author":"Jo","year":"2016","journal-title":"Surg Oncol Clin North Am"},{"issue":"10","key":"r2-20240731","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.diii.2017.06.006","article-title":"Diagnostic value of (18)F-FDG-PET\/CT for the follow-up and restaging of soft tissue sarcomas in adults","volume":"98","author":"Kassem","year":"2017","journal-title":"Diagn Interv Imaging"},{"issue":"6","key":"r3-20240731","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MNM.0000000000001002","article-title":"The role of 18F-FDG PET\/CT in soft tissue sarcoma","volume":"40","author":"Sambri","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"8","key":"r4-20240731","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1586\/14737140.6.8.1241","article-title":"Role of PET\/PET-CT in the management of sarcomas","volume":"6","author":"Kumar","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"r5-20240731","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/157340511796411186","article-title":"Quantitative techniques in PET-CT imaging","volume":"7","author":"Basu","year":"2011","journal-title":"Curr Med Imaging Rev"},{"key":"r6-20240731","first-page":"1","article-title":"Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study","volume":"2011","author":"Tian","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"8","key":"r7-20240731","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1007\/s00330-015-3654-y","article-title":"Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence","volume":"25","author":"Fendler","year":"2015","journal-title":"Eur Radiol"},{"issue":"1","key":"r8-20240731","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41824-021-00110-5","article-title":"Clinical value of baseline 18F-FDG PET\/CT in soft tissue sarcomas","volume":"5","author":"Reyes Marl\u00e9s","year":"2021","journal-title":"Eur J Hybrid Imaging"},{"issue":"7","key":"r9-20240731","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2967\/jnumed.111.101733","article-title":"Noise considerations for PET quantification using maximum and peak standardized uptake value","volume":"53","author":"Lodge","year":"2012","journal-title":"J Nucl Med"},{"issue":"1","key":"r10-20240731","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12149-018-1298-0","article-title":"Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas","volume":"33","author":"Kitao","year":"2019","journal-title":"Ann Nucl Med"},{"issue":"6","key":"r11-20240731","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/cancers11060790","article-title":"Neoadjuvant pazopanib treatment in high-risk soft tissue sarcoma: a quantitative dynamic (18)F-FDG PET\/CT study of the German Interdisciplinary Sarcoma Group","volume":"11","author":"Sachpekidis","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"r12-20240731","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cpet.2018.05.011","article-title":"PET in the diagnostic management of soft tissue sarcomas of musculoskeletal origin","volume":"13","author":"Katal","year":"2018","journal-title":"PET Clin"},{"issue":"4","key":"r13-20240731","first-page":"233","article-title":"Functional image in soft tissue sarcomas: an update of the indications of (18)F-FDG-PET\/CT","volume":"39","author":"Rodr\u00edguez-Alfonso","year":"2020","journal-title":"Rev Espanola Med Nucl E Imagen Mol"},{"issue":"13","key":"r14-20240731","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.2001.19.13.3203","article-title":"Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas","volume":"19","author":"Eilber","year":"2001","journal-title":"J Clin Oncol"},{"issue":"5","key":"r15-20240731","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00432-019-02885-4","article-title":"Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma","volume":"145","author":"Gannon","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"r16-20240731","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.blo.0000238864.69486.59","article-title":"Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma","volume":"455","author":"Menendez","year":"2007","journal-title":"Clin Orthopaedics Relat Res"},{"issue":"1","key":"r17-20240731","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cam4.4428","article-title":"Extent of tumor fibrosis\/hyalinization and infarction following neoadjuvant radiation therapy is associated with improved survival in patients with soft-tissue sarcoma","volume":"11","author":"Rao","year":"2022","journal-title":"Cancer Med"},{"issue":"8","key":"r18-20240731","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1158\/1078-0432.CCR-08-2537","article-title":"FDG-PET\/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas","volume":"15","author":"Benz","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"3","key":"r19-20240731","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1158\/1078-0432.CCR-07-1762","article-title":"Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas","volume":"14","author":"Evilevitch","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"7","key":"r20-20240731","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/RLU.0b013e3182175856","article-title":"PET\/CT allows stratification of responders to neoadjuvant chemotherapy for high-grade sarcoma: a prospective study","volume":"36","author":"Tateishi","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"2","key":"r21-20240731","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/cncr.20769","article-title":"Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy","volume":"103","author":"Schuetze","year":"2005","journal-title":"Cancer"},{"issue":"7","key":"r22-20240731","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1158\/1078-0432.CCR-11-2139","article-title":"18F-FDG-PET\/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy","volume":"18","author":"Herrmann","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"r23-20240731","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cncr.23592","article-title":"A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma","volume":"113","author":"Pervaiz","year":"2008","journal-title":"Cancer"},{"issue":"10","key":"r24-20240731","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1470-2045(17)30622-8","article-title":"Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial","volume":"18","author":"Seddon","year":"2017","journal-title":"Lancet Oncol"},{"issue":"2","key":"r25-20240731","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"S2","key":"r26-20240731","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1634\/theoncologist.13-S2-32","article-title":"Selection of response criteria for clinical trials of sarcoma treatment","volume":"13","author":"Schuetze","year":"2008","journal-title":"Oncologist"},{"issue":"13","key":"r27-20240731","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"r28-20240731","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1148\/radiol.2512081403","article-title":"High-grade soft-tissue sarcomas: tumor response assessment\u2014pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria","volume":"251","author":"Stacchiotti","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"r29-20240731","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12957-018-1462-y","article-title":"Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304","volume":"16","author":"Tanaka","year":"2018","journal-title":"World J Surg Oncol"},{"issue":"7","key":"r30-20240731","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejso.2010.05.021","article-title":"The significance of size change of soft tissue sarcoma during preoperative radiotherapy","volume":"36","author":"Miki","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"r31-20240731","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejca.2016.05.023","article-title":"Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma: an analysis of the EORTC 62012 study of the EORTC STBSG","volume":"64","author":"Gr\u00fcnwald","year":"2016","journal-title":"Eur J Cancer"},{"key":"r32-20240731","doi-asserted-by":"crossref","first-page":"103309","DOI":"10.1016\/j.critrevonc.2021.103309","article-title":"Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: where do we stand?","volume":"160","author":"Gennaro","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"suppl 1","key":"r33-20240731","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"issue":"3","key":"r34-20240731","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1148\/radiol.2019181659","article-title":"Soft-tissue sarcomas: assessment of MRI features correlating with histologic grade and patient outcome","volume":"291","author":"Cromb\u00e9","year":"2019","journal-title":"Radiology"},{"issue":"3","key":"r35-20240731","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1148\/radiol.2015142463","article-title":"Multiparametric assessment of treatment response in high-grade soft-tissue sarcomas with anatomic and functional MR imaging sequences","volume":"278","author":"Soldatos","year":"2016","journal-title":"Radiology"},{"issue":"11","key":"r36-20240731","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2967\/jnumed.119.226761","article-title":"(18)F-FDG PET\/MRI for therapy response assessment of isolated limb perfusion in patients with soft-tissue sarcomas","volume":"60","author":"Grueneisen","year":"2019","journal-title":"J Nucl Med"},{"issue":"2","key":"r37-20240731","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2106\/JBJS.M.00062","article-title":"Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome","volume":"96","author":"Eary","year":"2014","journal-title":"J Bone Joint Surg"},{"issue":"4","key":"r38-20240731","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2967\/jnumed.114.152462","article-title":"PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma","volume":"56","author":"Fendler","year":"2015","journal-title":"J Nucl Med"},{"issue":"9","key":"r39-20240731","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","article-title":"Radiomics: the process and the challenges","volume":"30","author":"Kumar","year":"2012","journal-title":"Magn Reson Imaging"},{"issue":"2","key":"r40-20240731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.JMI.5.2.024502","article-title":"Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma","volume":"5","author":"Wolsztynski","year":"2018","journal-title":"J Med Imaging"},{"issue":"14","key":"r41-20240731","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1088\/0031-9155\/60\/14\/5471","article-title":"A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities","volume":"60","author":"Valli\u00e8res","year":"2015","journal-title":"Phys Med Biol"},{"issue":"10","key":"r42-20240731","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00256-016-2440-5","article-title":"Comparison of MRI and PET-CT in detecting the loco-regional recurrence of soft tissue sarcomas during surveillance","volume":"45","author":"Park","year":"2016","journal-title":"Skeletal Radiol"},{"issue":"4","key":"r43-20240731","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3892\/ol.2014.1876","article-title":"Role of FDG-PET\/CT for monitoring soft tissue tumors","volume":"7","author":"Hoshi","year":"2014","journal-title":"Oncol Lett"},{"issue":"4","key":"r44-20240731","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jacr.2015.12.019","article-title":"ACR appropriateness criteria follow-up of malignant or aggressive musculoskeletal tumors","volume":"13","author":"Roberts","year":"2016","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"r45-20240731","doi-asserted-by":"crossref","first-page":"758","DOI":"10.6004\/jnccn.2016.0078","article-title":"Soft tissue sarcoma, version 2.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"von Mehren","year":"2016","journal-title":"J Natl Compr Cancer Netw"},{"issue":"10","key":"r46-20240731","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/MNM.0b013e328356741f","article-title":"18F-FDG-PET\/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas","volume":"33","author":"Eugene","year":"2012","journal-title":"Nucl Med Commun"},{"issue":"8","key":"r47-20240731","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/RLU.0b013e318217ae2e","article-title":"Additional Benefit of F-18 FDG PET\/CT in the staging and follow-up of pediatric rhabdomyosarcoma","volume":"36","author":"Ricard","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"6","key":"r48-20240731","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1148\/rg.336125105","article-title":"Identifying and distinguishing treatment effects and complications from malignancy at FDG PET\/CT","volume":"33","author":"Ulaner","year":"2013","journal-title":"RadioGraphics"},{"issue":"7","key":"r49-20240731","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.rlu.0000129124.52554.92","article-title":"Iatrogenic artifacts on whole-body F-18 FDG PET imaging","volume":"29","author":"Bhargava","year":"2004","journal-title":"Clin Nucl Med"},{"issue":"5","key":"r50-20240731","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","article-title":"Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma","volume":"25","author":"Juweid","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"r51-20240731","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00256-002-0586-9","article-title":"FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses","volume":"32","author":"Aoki","year":"2003","journal-title":"Skeletal Radiol"},{"issue":"28","key":"r52-20240731","doi-asserted-by":"crossref","first-page":"e1142","DOI":"10.1097\/MD.0000000000001142","article-title":"Semi-quantitative calculations of primary tumor metabolic activity using F-18 FDG PET\/CT as a predictor of survival in 92 patients with high-grade bone or soft tissue sarcoma","volume":"94","author":"Andersen","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"r53-20240731","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.3390\/jcm9082549","article-title":"Diagnostic and clinical impact of 18F-FDG PET\/CT in staging and restaging soft-tissue sarcomas of the extremities and trunk: mono-institutional retrospective study of a sarcoma referral center","volume":"9","author":"Annovazzi","year":"2020","journal-title":"J Clin Med"},{"key":"r54-20240731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/960194","article-title":"FDG PET\/CT in initial staging of adult soft-tissue sarcoma","volume":"2012","author":"Roberge","year":"20122012","journal-title":"Sarcoma"},{"issue":"06","key":"r55-20240731","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1055\/s-0040-1721097","article-title":"Therapy-related imaging findings in patients with sarcoma","volume":"24","author":"Bloem","year":"2020","journal-title":"Semin Musculoskelet Radiol"},{"issue":"5","key":"r56-20240731","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00256-014-1832-7","article-title":"Prognostic value of 18F-FDG PET\/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters","volume":"43","author":"Hong","year":"2014","journal-title":"Skeletal Radiol"},{"issue":"1","key":"r57-20240731","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12880-020-00486-z","article-title":"Differentiation of soft tissue and bone sarcomas from benign lesions utilizing (18)F-FDG PET\/CT-derived parameters","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Med Imaging"},{"issue":"12","key":"r58-20240731","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1007\/s00259-013-2511-y","article-title":"Total lesion glycolysis by 18F-FDG PET\/CT is a reliable predictor of prognosis in soft-tissue sarcoma","volume":"40","author":"Choi","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"r59-20240731","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1245\/s10434-017-5996-y","article-title":"Cost-effectiveness of surveillance for distant recurrence in extremity soft tissue sarcoma","volume":"24","author":"Royce","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"r60-20240731","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ocl.2015.03.001","article-title":"PET imaging in sarcoma","volume":"46","author":"Becher","year":"2015","journal-title":"Orthop Clin North Am"},{"issue":"1","key":"r61-20240731","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00247-016-3720-x","article-title":"Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012","volume":"47","author":"Johnsen","year":"2017","journal-title":"Pediatr Radiol"},{"issue":"5","key":"r62-20240731","first-page":"306","article-title":"PET\/RM simult\u00e1nea vs. PET\/TC en oncolog\u00eda. Una revisi\u00f3n sistem\u00e1tica","volume":"35","author":"Riola-Parada","year":"2016","journal-title":"Rev Esp Med Nucl E Imagen Mol"},{"issue":"3","key":"r63-20240731","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.mri.2015.10.027","article-title":"Synergistic role of simultaneous PET\/MRI-MRS in soft tissue sarcoma metabolism imaging","volume":"34","author":"Zhang","year":"2016","journal-title":"Magn Reson Imaging"},{"issue":"11","key":"r64-20240731","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.18632\/oncotarget.7552","article-title":"Development of 89Zr-Ontuxizumab for in vivo TEM-1\/endosialin PET applications","volume":"7","author":"Lange","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"r65-20240731","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/1078-0432.CCR-07-4294","article-title":"Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine","volume":"14","author":"Buck","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"5","key":"r66-20240731","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1158\/1078-0432.CCR-03-0040","article-title":"Detection and grading of soft tissue sarcomas of the extremities with (18)F-3\u2032-fluoro-3\u2032-deoxy-L-thymidine","volume":"10","author":"Cobben","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"12","key":"r67-20240731","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/cncr.26630","article-title":"3\u2032-deoxy-3\u2032-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response","volume":"118","author":"Benz","year":"2012","journal-title":"Cancer"},{"issue":"5","key":"r68-20240731","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00259-002-1096-7","article-title":"[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression","volume":"30","author":"Rajendran","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"r70-20240731","first-page":"1","article-title":"Fusion of FDG-PET image and clinical features for prediction of lung metastasis in soft tissue sarcomas","volume":"2020","author":"Deng","year":"2020","journal-title":"Comput Math Methods Med"},{"issue":"9","key":"r71-20240731","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00259-021-05197-3","article-title":"Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure","volume":"48","author":"Wang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"r72-20240731","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1007\/s00259-019-04468-4","article-title":"PET image denoising using unsupervised deep learning","volume":"46","author":"Cui","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"r73-20240731","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1118\/1.4928400","article-title":"Prediction of standard-dose brain PET image by using MRI and low-dose brain [18F]FDG PET images","volume":"42","author":"Kang","year":"2015","journal-title":"Med Phys"},{"issue":"2","key":"r74-20240731","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1088\/0031-9155\/61\/2\/791","article-title":"Predicting standard-dose PET image from low-dose PET and multimodal MR images using mapping-based sparse representation","volume":"61","author":"Wang","year":"2016","journal-title":"Phys Med Biol"}],"container-title":["JBJS Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.RVW.22.00131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:38:23Z","timestamp":1787751503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.RVW.22.00131"}},"subtitle":["A Comprehensive Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":73,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.rvw.22.00131","relation":{},"ISSN":["2329-9185"],"issn-type":[{"value":"2329-9185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}